1. Home
  2. TMDX vs SPNT Comparison

TMDX vs SPNT Comparison

Compare TMDX & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • SPNT
  • Stock Information
  • Founded
  • TMDX 1998
  • SPNT 2011
  • Country
  • TMDX United States
  • SPNT Bermuda
  • Employees
  • TMDX N/A
  • SPNT N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SPNT Property-Casualty Insurers
  • Sector
  • TMDX Health Care
  • SPNT Finance
  • Exchange
  • TMDX Nasdaq
  • SPNT Nasdaq
  • Market Cap
  • TMDX 2.3B
  • SPNT 2.2B
  • IPO Year
  • TMDX 2019
  • SPNT N/A
  • Fundamental
  • Price
  • TMDX $123.56
  • SPNT $19.28
  • Analyst Decision
  • TMDX Buy
  • SPNT Hold
  • Analyst Count
  • TMDX 10
  • SPNT 1
  • Target Price
  • TMDX $127.33
  • SPNT $17.00
  • AVG Volume (30 Days)
  • TMDX 830.9K
  • SPNT 525.3K
  • Earning Date
  • TMDX 07-30-2025
  • SPNT 07-31-2025
  • Dividend Yield
  • TMDX N/A
  • SPNT N/A
  • EPS Growth
  • TMDX N/A
  • SPNT N/A
  • EPS
  • TMDX 1.41
  • SPNT 0.96
  • Revenue
  • TMDX $488,227,000.00
  • SPNT $2,682,300,000.00
  • Revenue This Year
  • TMDX $34.07
  • SPNT $11.96
  • Revenue Next Year
  • TMDX $20.76
  • SPNT $6.66
  • P/E Ratio
  • TMDX $87.63
  • SPNT $20.13
  • Revenue Growth
  • TMDX 64.43
  • SPNT N/A
  • 52 Week Low
  • TMDX $55.00
  • SPNT $11.96
  • 52 Week High
  • TMDX $177.37
  • SPNT $20.00
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 45.61
  • SPNT 52.99
  • Support Level
  • TMDX $139.31
  • SPNT $18.96
  • Resistance Level
  • TMDX $145.50
  • SPNT $20.00
  • Average True Range (ATR)
  • TMDX 5.88
  • SPNT 0.51
  • MACD
  • TMDX -2.71
  • SPNT -0.09
  • Stochastic Oscillator
  • TMDX 12.94
  • SPNT 44.62

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About SPNT SiriusPoint Ltd.

SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.

Share on Social Networks: